A Genetic Screen for Temperature-sensitive Morphogenesis-defective Caenorhabditis elegans Mutants
Congratulations to Bruce A. Bowerman, one of our esteemed customer published a paper this week in G3: Genes, Genomes,
Get a better understanding and prediction for pre-clinical drug trials
Allowing comprehension and predicting of human responses earlier, while also offering ethical alternatives to animal testing.
Congratulations to Bruce A. Bowerman, one of our esteemed customer published a paper this week in G3: Genes, Genomes,
Role of Daf-2 insulin signaling in the embryonic elongation of C. elegans, a daf-2 loss of
THE GENETICS OF CAENORHABDITIS ELEGANS (1974) Brenner shed light on the Caenorhabditis elegans in 1974 with his study demonstrating
DEEPTECH START-UP : AN INNOVATIVE TRAINING NETWORKS Cherry Biotech: Learn to become an innovator! Cherry Biotech
A step for the development of the CubiX product line Congratulation to Dr. W. Kaelin, Dr.
2 YEARS INDIVIDUAL FELLOWSHIP IN DEEPTECH START-UP Cherry Biotech: Learn to become an innovator! Cherry Biotech
The CubiX Mark I evolves, Here are the new features: It has the same features as
CubiX was presented in Adelaide Thanks to Benjamin Thierry and The South Australian Government Department of
Cherry Biotech is in Adelaide : Cherry Biotech is at the University of South Australia (Adelaide) until June 22 to discuss and collaborate
Our exclusive interview of Marjorie Villien during the 2017 World Congress of organ on chip: As a
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com